-
Product Insights
NewGastroenteritis – Drugs In Development, 2024
Empower your strategies with our Gastroenteritis – Drugs In Development, 2024 report and make more profitable business decisions. Gastroenteritis is an infection of the gut. Symptoms include stomach pain, cramping, fever, nausea, and a headache. Causes of gastroenteritis include contaminated food or water, and contact with someone who has the virus. Treatment includes antibiotics, anti-emetic and anti-diarrheal medications. The Gastroenteritis drugs in development market research report provide comprehensive information on the therapeutics under development for Gastroenteritis, complete with analysis by stage...
-
Product Insights
NewGastrointestinal Radiation Toxicity – Drugs In Development, 2024
Empower your strategies with our Gastrointestinal Radiation Toxicity – Drugs In Development, 2024 report and make more profitable business decisions. Gastrointestinal radiation toxicity occurs following external beam therapy with respect to the gastrointestinal tract, the severity of toxicity is reported as grades to different symptoms or clinical manifestations ranging from minor symptomatic changes to severe life threatening complications. The Gastrointestinal Radiation Toxicity drugs in development market research report provide comprehensive information on the therapeutics under development for Gastrointestinal Radiation Toxicity, complete...
-
Product Insights
NewChemotherapy Induced Nausea and Vomiting – Drugs In Development, 2024
Empower your strategies with our Chemotherapy Induced Nausea and Vomiting – Drugs In Development, 2024 report and make more profitable business decisions. Chemotherapy-induced nausea and vomiting (CINV) is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Other symptoms include a rapid heart rate, sweating, dizziness, and increased saliva. Risk factors include age, drug, dose, and the schedule and route of the drug's administration. The Chemotherapy Induced Nausea and Vomiting drugs in development market research report provide comprehensive information...
-
Product Insights
NewHelicobacter pylori Infections – Drugs In Development, 2024
Empower your strategies with our Helicobacter pylori Infections – Drugs In Development, 2024 report and make more profitable business decisions. Helicobacter pylori (H. pylori) infection occurs when the Helicobacter pylori (H. pylori) bacteria infect the stomach, typically during childhood. A leading cause of stomach ulcers, this infection is asymptomatic for many, with over half of the global population potentially affected. Recognition often arises when peptic ulcer symptoms manifest, prompting healthcare providers to test for H. pylori. Peptic ulcers, affecting the stomach...
-
Product Insights
NewDiarrhea – Drugs In Development, 2024
Empower your strategies with our Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. The Diarrhea drugs in development market research report...
-
Product Insights
NewIrritable Bowel Syndrome – Drugs In Development, 2024
Empower your strategies with our Irritable Bowel Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects the large intestine (colon). Symptoms include cramping, abdominal pain, bloating gas, diarrhea, backache, muscle pains, poor appetite, and constipation. These symptoms can be triggered by food, stress, and hormones. Risk factors include age and family history. Treatment includes anti-diarrheal, anticholinergic, antidepressant, and antibiotic medications. The Irritable Bowel Syndrome drugs in...
-
Product Insights
NewKidney Fibrosis – Drugs In Development, 2024
Empower your strategies with our Kidney Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis and may lead to detrimental effects on the kidney functioning. Predisposing factors are trauma, injury, infections, surgery, environmental factors, and exposure to chemicals or radiation. Symptoms include pain, problems related to urination, nausea, and vomiting. The condition may be managed with...
-
Product Insights
NewChikungunya Fever – Drugs In Development, 2024
Empower your strategies with our Chikungunya Fever – Drugs In Development, 2024 report and make more profitable business decisions. Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting, and rash and fever. Treatment includes use of non-steroidal...
-
Product Insights
NewGastrointestinal Tumor – Drugs In Development, 2024
Empower your strategies with our Gastrointestinal Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Gastrointestinal (GI) tumors refer to abnormal growths or neoplasms that develop in various parts of the digestive system, which includes the esophagus, stomach, intestines (small and large), liver, gallbladder, and pancreas. These tumors can be benign (non-cancerous) or malignant (cancerous). The Gastrointestinal Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with...
-
Product Insights
NewRadiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024
Empower your strategies with our Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Radiation toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of ionizing radiation over a very short period of time (usually a matter of minutes). The root cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues. Symptoms include bleeding from...